(Edinburgh, Scotland) — KDIGO (Kidney Disease: Improving Global Outcomes) has concluded a 3-day Controversies Conference on Autosomal Dominant Polycystic Kidney Disease (ADPKD) with consensus recommendations from more than 60 globally-recognized experts. Vicente Torres, MD, PhD of the Mayo Clinic in Rochester, Minnesota and Olivier Devuyst, MD, PhD of the University of Zurich in Switzerland chaired